Modified acellular porcine corneal matrix in deep lamellar transplantation of rabbit cornea. (March 2020)

• Record Type: Journal Article
• Authors: Wang, Qian; Zhou, Hang; Sun, Yongqiang; Cao, Chengbo; Pang, Kunpeng
• Is Part Of: Journal of biomaterials applications. Volume 34:Number 8(2020)
• Page Start: 1092
• Page End: 1104
• Publication Date: 2020-03
• Subjects: Corneal tissue engineering -- decellularization -- crosslinking -- 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide -- enhanced biocompatibility; Biomedical engineering -- Periodicals; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1177/0885328219898372
• Languages: English
• ISSNs: 0885-3282

Abstract

This study presents to develop a modified acellular porcine corneal matrix (MAPCM) to maintain high transparency, stability and biocompatibility as a rabbit deep cornea replacement using 1-ethyl-3–(3-dimethylaminopropyl)-carbodiimide crosslinking and a mild decellularization technique. Scaffolds are translucent and remain higher amount of glycosaminoglycans after decellularization than acellular porcine corneal matrix (APCM). Enzymatic degradation kinetics and mechanical properties of scaffolds are regulated by 1-ethyl-3–(3-dimethylaminopropyl)-carbodiimide -crosslinking density. The porous structure and ultrastructure of collagenous lamellae are maintained, and the pore size of MAPCM crosslinked with 0.5% (w/v) 1-ethyl-3–(3-dimethylaminopropyl)-carbodiimide is 13.26 ± 1.65 µm, similar to that of normal porcine cornea. The transmittance of MAPCM gets 79.1 ± 0.45 to 92.7 ± 1.4% in the visible light range. Results from a CCK-8 assay indicate that MAPCM gets higher cell proliferation rate of rabbit corneal stroma cells than APCM. Since collagen fibres structural integrity and regularity of MAPCM are retained after crosslinking, the opacity and stability of MAPCM are better than those of APCM within 4 weeks of animal implantation. In addition, there is no indication of an immune response or neovascularization in or around the transplanted disc. These results reveal that MAPCM may be a more suitable scaffold for corneal substitute construction.